1. Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer. (August 2013) Authors: Viola, David; Cappagli, Virginia; Elisei, Rossella Journal: Future oncology Issue: Volume 9:Number 8(2013) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer. (August 2013) Authors: Viola, David; Cappagli, Virginia; Elisei, Rossella Journal: Future oncology Issue: Volume 9:Number 8(2013) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer. (August 2013) Authors: Viola, David; Cappagli, Virginia; Elisei, Rossella Journal: Future oncology Issue: Volume 9:Number 8(2013) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer. (August 2013) Authors: Viola, David; Cappagli, Virginia; Elisei, Rossella Journal: Future oncology Issue: Volume 9:Number 8(2013) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Chylous effusions in advanced medullary thyroid cancer patients treated with selpercatinib. Issue 6 (29th November 2022) Authors: Prete, Alessandro; Gambale, Carla; Cappagli, Virginia; Bottici, Valeria; Rossi, Piercarlo; Caciagli, Marco; Papini, Piermarco; Taddei, Donatella; Ortori, Simona; Gabbrielli, Luciano; Celi, Alessandro; Materazzi, Gabriele; Elisei, Rossella; Matrone, Antonio Journal: European journal of endocrinology Issue: Volume 187:Issue 6(2022) Page Start: 905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response. Issue 2 (February 2020) Authors: Valerio, Laura; Bottici, Valeria; Matrone, Antonio; Piaggi, Paolo; Viola, David; Cappagli, Virginia; Agate, Laura; Molinaro, Eleonora; Ciampi, Raffaele; Tacito, Alessia; Ramone, Teresa; Romei, Cristina; Elisei, Rossella Journal: Endocrine-related cancer Issue: Volume 27:Issue 2(2020) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response. Issue 2 (February 2020) Authors: Valerio, Laura; Bottici, Valeria; Matrone, Antonio; Piaggi, Paolo; Viola, David; Cappagli, Virginia; Agate, Laura; Molinaro, Eleonora; Ciampi, Raffaele; Tacito, Alessia; Ramone, Teresa; Romei, Cristina; Elisei, Rossella Journal: Endocrine-related cancer Issue: Volume 27:Issue 2(2020) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations. Issue 11 (28th July 2016) Authors: Romei, Cristina; Casella, Francesca; Tacito, Alessia; Bottici, Valeria; Valerio, Laura; Viola, David; Cappagli, Virginia; Matrone, Antonio; Ciampi, Raffaele; Piaggi, Paolo; Ugolini, Clara; Torregrossa, Liborio; Basolo, Fulvio; Materazzi, Gabriele; Vitti, Paolo; Elisei, Rossella Journal: Journal of medical genetics Issue: Volume 53:Issue 11(2016) Page Start: 729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH. Issue 4 (October 2020) Authors: Campopiano, Maria Cristina; Podestà, Debora; Bianchi, Francesca; Giani, Carlotta; Agate, Laura; Bottici, Valeria; Cappagli, Virginia; Lorusso, Loredana; Matrone, Antonio; Puleo, Luciana; Valerio, Laura; Viola, David; Piaggi, Paolo; Elisei, Rossella; Molinaro, Eleonora Journal: European journal of endocrinology Issue: Volume 183:Issue 4(2020) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH. Issue 4 (October 2020) Authors: Campopiano, Maria Cristina; Podestà, Debora; Bianchi, Francesca; Giani, Carlotta; Agate, Laura; Bottici, Valeria; Cappagli, Virginia; Lorusso, Loredana; Matrone, Antonio; Puleo, Luciana; Valerio, Laura; Viola, David; Piaggi, Paolo; Elisei, Rossella; Molinaro, Eleonora Journal: European journal of endocrinology Issue: Volume 183:Issue 4(2020) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗